U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

Over 1,700 opioid pills, a firearm, and U.S. currency were seized from North’s home. North, a convicted felon, faces multiple charges related to drug distribution and firearm possession.

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...

Utah health officials and medical providers are celebrating a 41% decrease in opioid prescriptions in an effort to reduce ...

A tablet and bottle of the JOURNAVX (suzetrigine) medication. (AP) The drug will be priced at $15.50 per pill, making it significantly more expensive than opioids, which are often available as ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.

Studies show it is more effective than a placebo but does not outperform traditional opioid-acetaminophen pain relievers. Journavx will cost $15.50 per pill—significantly more than generic ...